Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 21304509)

1.

Aerobic glycolysis: a novel target in kidney cancer.

Shuch B, Linehan WM, Srinivasan R.

Expert Rev Anticancer Ther. 2013 Jun;13(6):711-9. doi: 10.1586/era.13.57. Review.

2.

Metabolism of kidney cancer: from the lab to clinical practice.

Sudarshan S, Karam JA, Brugarolas J, Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B, Linehan WM.

Eur Urol. 2013 Feb;63(2):244-51. doi: 10.1016/j.eururo.2012.09.054. Epub 2012 Sep 28. Review.

3.

NRF2 and cancer: the good, the bad and the importance of context.

Sporn MB, Liby KT.

Nat Rev Cancer. 2012 Jul 19;12(8):564-71. doi: 10.1038/nrc3278.

4.

A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.

Sivanand S, Peña-Llopis S, Zhao H, Kucejova B, Spence P, Pavia-Jimenez A, Yamasaki T, McBride DJ, Gillen J, Wolff NC, Morlock L, Lotan Y, Raj GV, Sagalowsky A, Margulis V, Cadeddu JA, Ross MT, Bentley DR, Kabbani W, Xie XJ, Kapur P, Williams NS, Brugarolas J.

Sci Transl Med. 2012 Jun 6;4(137):137ra75. doi: 10.1126/scitranslmed.3003643.

5.

State of the science: an update on renal cell carcinoma.

Jonasch E, Futreal PA, Davis IJ, Bailey ST, Kim WY, Brugarolas J, Giaccia AJ, Kurban G, Pause A, Frydman J, Zurita AJ, Rini BI, Sharma P, Atkins MB, Walker CL, Rathmell WK.

Mol Cancer Res. 2012 Jul;10(7):859-80. doi: 10.1158/1541-7786.MCR-12-0117. Epub 2012 May 25. Review.

6.

Stable isotope-resolved metabolomics and applications for drug development.

Fan TW, Lorkiewicz PK, Sellers K, Moseley HN, Higashi RM, Lane AN.

Pharmacol Ther. 2012 Mar;133(3):366-91. doi: 10.1016/j.pharmthera.2011.12.007. Epub 2011 Dec 23. Review.

7.

Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance.

van Spaendonck-Zwarts KY, Badeloe S, Oosting SF, Hovenga S, Semmelink HJ, van Moorselaar RJ, van Waesberghe JH, Mensenkamp AR, Menko FH.

Fam Cancer. 2012 Mar;11(1):123-9. doi: 10.1007/s10689-011-9491-5.

8.

Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2.

Kinch L, Grishin NV, Brugarolas J.

Cancer Cell. 2011 Oct 18;20(4):418-20. doi: 10.1016/j.ccr.2011.10.005.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk